Data discussed in summary suggest that post-LT HCV infection may be most amenable to therapy initiated on a prophylactic basis early in the post-LT course. However, a definitive comparison of the safety and efficacy of antiviral therapy initiated prophylactically versus on histological recurrence has not been performed, nor has any large study of antiviral therapy of post-LT HCV infection.
|Original language||English (US)|
|Issue number||10 SUPPL. 1|
|State||Published - Oct 1 2002|
ASJC Scopus subject areas